638 results on '"Kobinger, Gary P."'
Search Results
2. BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
3. Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic
4. Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters
5. SARS-CoV-2 molecular diagnosis at airports to minimize travel-related COVID-19 spread
6. A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines
7. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
8. Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
9. Computational genomics of Torque teno sus virus and Porcine circovirus in swine samples from Canada
10. Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials.
11. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
12. Gut microbiota modulation induced by Zika virus infection in immunocompetent mice
13. In vivo generation of collagen specific Tregs with AAV8 suppresses autoimmune responses and arthritis in DBA1 mice through IL10 production
14. Rhesus Macaques Show Increased Resistance To Repeated SHIV Intrarectal Exposure Following A Heterologous Regimen Of rVSV Vector Vaccine Expressing HIV Antigen
15. Contribution of Environment Sample-Based Detection to Ebola Outbreak Management
16. The Makona Variant of Ebola Virus Is Highly Lethal to Immunocompromised Mice and Immunocompetent Ferrets
17. Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms
18. Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
19. Medically Significant Vector-Borne Viral Diseases in Iran.
20. SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants.
21. Intramuscular Adeno-Associated Virus–Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice
22. Relationship Between Viremia and Specific Organ Damage in Ebola Patients : A Cohort Study
23. Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods
24. Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine
25. Taxonomy of the order Mononegavirales: update 2019
26. Taxonomy of the order Mononegavirales: second update 2018
27. Taxonomy of the order Mononegavirales: update 2018
28. BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
29. Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model
30. Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model
31. New filovirus disease classification and nomenclature
32. Taxonomy of the order Mononegavirales: update 2017
33. Progression of Ebola Therapeutics During the 2014–2015 Outbreak
34. Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice
35. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates
36. A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice
37. Taxonomy of the order Mononegavirales: update 2016
38. Structures of protective antibodies reveal sites of vulnerability on Ebola virus
39. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
40. Post-exposure therapy of filovirus infections
41. Ebola Virus Encodes Two microRNAs in Huh7-Infected Cells
42. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine
43. Retrospective Studies: Excellent Tools to Complement Surveillance
44. Viral pathogenesis: Unlocking Ebola persistence
45. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
46. Blood kinetics of Ebola virus in survivors and nonsurvivors
47. Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection
48. How to turn competitors into collaborators
49. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
50. Texas Professionals are Employing a One Health Approach to Protect the United States Against Biosecurity Threats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.